메뉴 건너뛰기




Volumn 4, Issue 6, 2001, Pages 339-346

HIV drug resistance and implications for the introduction of antiretroviral therapy in resource-poor countries

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

EID: 0035743976     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.2002.0235     Document Type: Article
Times cited : (18)

References (97)
  • 3
    • 0035793685 scopus 로고    scopus 로고
    • AIDS vaccine shows promise after years of frustration
    • (2001) Science , vol.291 , pp. 1686-1688
    • Cohen, J.1
  • 4
    • 0034631503 scopus 로고    scopus 로고
    • Accelerating the development and future availability of HIV-1 vaccines: Why, when, where, and how?
    • (2000) Lancet , vol.355 , pp. 2061-2066
    • Esparza, J.1    Bhamarapravati, N.2
  • 6
    • 0033807578 scopus 로고    scopus 로고
    • Human immunodeficiency virus vaccine development in developing countries: Are efficacy trials feasible?
    • (2000) J Hum Virol , vol.3 , pp. 193-214
    • Excler, J.L.1    Beyrer, C.2
  • 8
    • 0034116325 scopus 로고    scopus 로고
    • Ethical challenges of HIV vaccine trials in less developed nations: Conflict and consensus in the international arena
    • (2000) AIDS , vol.14 , pp. 1051-1057
    • Bayer, R.1
  • 19
    • 0029590776 scopus 로고
    • Effects of non-nucleosides inhibitors of human immunodeficiency virus type 1 in cell-free recombinant reverse transcriptase assay
    • (1995) J Biol Chem , vol.270 , pp. 31046-31051
    • Gu, Z.1    Quan, Y.2    Li, Z.3
  • 20
    • 2642704250 scopus 로고    scopus 로고
    • Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy
    • (1998) J Virol , vol.72 , pp. 2422-2428
    • Gunthard, H.F.1    Wong, J.K.2    Ignacio, C.C.3
  • 21
    • 0033022106 scopus 로고    scopus 로고
    • Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development
    • (1999) AIDS , vol.13 , pp. 661-667
    • Palmer, S.1    Shafer, R.W.2    Merigan, T.C.3
  • 29
    • 0028044916 scopus 로고
    • Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3′-azido-3′-deoxythymidine or 2′,3′-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro
    • (1994) Antimicrob Agents Chemother , vol.38 , pp. 288-293
    • Chong, K.T.1    Pagano, P.J.2    Hinshaw, R.R.3
  • 31
    • 0029153101 scopus 로고
    • Synergistic inhibition of HIV-1 reverse transcriptase DNA polymerase activity and virus replication in vitro by combinations of carboxanilide non-nucleoside compounds
    • (1995) Biochemistry , vol.34 , pp. 10106-10112
    • Fletcher, R.S.1    Arion, D.2    Borkow, G.3
  • 33
    • 0027214433 scopus 로고
    • Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in different resistance pattern than does treatment with single-drug therapy
    • (1993) J Virol , vol.67 , pp. 5353-5359
    • Balzarini, J.1    Karlsson, A.2    Perez-Perez, M.J.3
  • 39
    • 0028099251 scopus 로고
    • Resistance of HIV-1 reverse transcriptase against [2′,5′-bis-O-(tert-butyldimethylsily-3′-spiro-5″ -(4″-amino-1″, 2″-oxathiole-2″, 2″-dioxide)] (TIBO) derivatives is determined by the mutation Glu138-Lys on the p51 subunit
    • (1994) J Biol Chem , vol.269 , pp. 25255-25258
    • Jonckheere, H.1    Taymans, J.M.2    Balzarini, J.3
  • 43
    • 0033281851 scopus 로고    scopus 로고
    • Failure of HIV-1 protease inhibitors to fully suppress viral replication. Implications for salvage therapy
    • (1999) Adv Exptl Med Biol , vol.458 , pp. 175-182
    • Deeks, S.G.1
  • 46
    • 0032708315 scopus 로고    scopus 로고
    • High-dose saquinavir plus ritonavir: Long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response
    • (1999) J AIDS , vol.22 , pp. 132-138
    • Parades, R.1    Puig, T.2    Amo, A.3
  • 47
    • 0033601891 scopus 로고    scopus 로고
    • Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy
    • (1999) Eur J Med Res , vol.4 , pp. 54-58
    • Reiser, M.1    Salzberger, B.2    Steipel, A.3
  • 48
    • 0032700205 scopus 로고    scopus 로고
    • Antiretroviral therapy in 1999 for antiretroviral-naive individuals with HIV infection
    • (1999) AIDS , vol.13 , Issue.SUPPL. 1
    • Fischl, M.A.1
  • 51
    • 0028039607 scopus 로고
    • Generation of multiple drug resistance by sequential in vitro passage of the Human Immunodeficiency Virus type 1
    • (1994) Arch Virol , vol.36 , pp. 111-122
    • Gao, Q.1    Gu, Z.2    Salomon, H.3
  • 56
    • 0028172345 scopus 로고
    • Locations of anti-AIDS drug binding sites and resistance mutations in three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance
    • (1994) J Molec Biol , vol.243 , pp. 369-387
    • Tantillo, C.1    Ding, A.2    Jacobs-Molina, R.3
  • 59
    • 0032564526 scopus 로고    scopus 로고
    • Variations in HIV-1 pol gene associated with reduced sensitivity to anti-retroviral drugs in treatment-naïve patients
    • (1998) AIDS , vol.12 , pp. 2369-2375
    • Birk, B.1    Sonnerborg, A.2
  • 70
    • 0002674645 scopus 로고    scopus 로고
    • Final results of CPCRA 046: A pilot study of antiretroviral management based on plasma genotypic antiretroviral resistance testing (GART) in patients failing antiretroviral therapy
    • (1999) Antiviral Ther , vol.4 , Issue.SUPPL. 1
    • Baxter, J.D.1    Mayers, D.2    Wentworth, D.N.3
  • 74
  • 77
    • 0035292858 scopus 로고    scopus 로고
    • International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance
    • (2001) J Acquir Immune Defic Syndr , vol.26 , Issue.SUPPL. 1
    • Deeks, S.G.1
  • 85
    • 0033635835 scopus 로고    scopus 로고
    • Prevention of perinatal HIV infection. What do we know? Where should future research go?
    • (2000) Ann NY Acad Sci , vol.918 , pp. 45-52
    • Fowler, M.G.1
  • 86
    • 0033523454 scopus 로고    scopus 로고
    • Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
    • (1999) Lancet , vol.354 , pp. 795-802
    • Guay, L.A.1    Musoke, P.2    Fleming, T.3
  • 89
    • 0032565098 scopus 로고    scopus 로고
    • For the INCAS Study Group: A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients. The INCAS trial
    • (1998) JAMA , vol.279 , pp. 930-937
    • Montaner, J.S.G.1    Reiss, P.2    Cooper, D.3
  • 91
    • 0035138694 scopus 로고    scopus 로고
    • The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy
    • (2001) Drugs , vol.61 , Issue.1 , pp. 19-26
    • Moyle, G.1
  • 97
    • 0035115259 scopus 로고    scopus 로고
    • Structured treatment interruption in HIV infection
    • (2001) AIDS Read , vol.11 , Issue.2 , pp. 99-102
    • Benson, C.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.